WHO. The World Health Report 2002. Reducing risks, promoting healthy life. MDI.WHR202.A. The World Health Organization, Geneva, 2002.
Murray CJ. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. C.J. Murray, A.D. Lopez. Lancet, 1997, 349: 1498-1504.
Lopez AD. Chronic obstructive pulmonary disease: current burden and future projections. A.D. Lopez , K. Shibuya, C. Rao et al. Eur Respir J., 2006, 27 (2): 188-207.
Pauwels RA. Burden and clinical features of chronic obstructive pulmonary disease (COPD). R.A. Pauwels, K.F. Rabe. Lancet, 2004, 364: 613-620.
Donaldson GC Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. G.C. Donaldson, T.A. Seemungal, A. Bhowmik, J.A. Wedzicha. Thorax, 2002, 57: 847-852.
Seemungal T.A. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. T.A. Seemungal, G.C. Donaldson, E.A. Paul et al. Am] Respir Crit Care Med., 1998. 157: 1418-1422.
Miravitlles M. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. M. Miravitlles., C. Murio., T. Guerrero et al. Chest, 2002, 121: 1449-1455.
Gunen H. Factors affecting survival of hospitalized patients with COPD. H. Gunen, S.S. Hacievliyagil, F. Kosar et al. Eur Respir]., 2005, 26: 234-241.
Soler-Cataluna JJ. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. J.J. Soler-Cataluna, M.A. Martinez-Garcia, P Roman Sanchez et al. Thorax 2005, 60: 925-931.
Wedzicha J.A. Exacerbations of chronic obstructive pulmonary disease. J.A. Wedzicha, G.C Donaldson. Respir Care. 2003, 48 (12): 1204-13.
White AJ. Chronic obstructive pulmonary disease: 6. The aetiology of exacerbation of chronic obstructive pulmonary disease. AJ. White, S. Gompertz., R.A. Stockley. Thorax, 2003, 58: 73-80.
Gompertz S. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. S. Gompertz, C. O'Brien, D.L. Bayley et al. Eur Respir J., 2001, 17: 1112-1119.
Cote CG. Impact of COPD Exacerbations on Patient-Centered Outcomes. C.G. Cote, L.J. Dordelly, B.R. Celli. Chest. 2007, 131: 696-704.
Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO workshop report. Bethesda, National Heart, Lung and Blood Institute; Update 2007, GOLD website (http://wwwgoldcopd.com).http://wwwgoldcopd.com)
Дворецкий Л.И. Инфекционные обострения ХОБЛ. Л.И. Дворецкий. Лечащий врач, 2007, (3): 80-84.
Anthonisen NR. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. N.R. Anthonisen, J. Manfreda, C.P Warren et al. Ann Intern. Med. 1987, 106: 196-204.
Wedzicha JA. Exacerbations of chronic obstructive pulmonary disease. J.A. Wedzicha, G.C. Donaldson. Respir Care. 2003, 48(12): 1204-1213.
Monso E. Risk factors for lower airway bacterial colonization in chronic bronchitis. E. Monso, A. Rosell, G. Bonet et al. Eur Respir J, 1999, 13: 338-342.
Soler N. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. N. Soler, S. Ewig, A. Torres et al. Eur Respir J, 1999, 14: 1015-1022.
Patel IS. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. I.S. Patel, T.A. Seemungal, M. Wilks et al. Thorax 2002, 57: 759-764.
White AJ. The aetiology of exacerbations of chronic obstructive pulmonary disease. A.J. White, S. Gompertz, R.A. Stockle. Thorax, 2003, 58: 73-80.
Monso E. Bacterial infection in chronic obstructive pulmonary disease: a study of stable and exacerbated outpatients using the protected specimen brush. E. Monso, J. Ruiz, J. Manterola et al. AmJ Respir Crit Care Med, 1995, 152: 1316-1320.
Lieberman D. Serological evidence of Mycoplasma pneumoniae infection in acute exacerbation of COPD. D. Lieberman,. Lieberman D, M. Ben-Yaakov et al. Diagn Microbiol Infect Dis, 2002, 44 (1): 1-6.
Lieberman D. Infectious etiologies in acute exacerbation of COPD. D. Lieberman, D. Lieberman, M. Ben-Yaakov et al. Diagn Microbiol Infect Dis 2001, 40: 95-102.
Soler N. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. N. Soler., A. Torres, S. Ewig et al. Am J Respir Crit Care Med, 1998, 157: 1498-1505.
Eller J. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. J. Eller, A. Ede, T. Schaberg et al. Chest 1998, 113: 1542-1548.
Papi A, Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations. A. Papi, C.M. Bellettato, F. Braccioni et al. Am J Respir Crit Care Med 2006, 173: 1114-1121.
Tashkin D. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebocontrolled, randomised trial. D. Tashkin, R. Kanner, W. Bailey et al. Lancet 2001, 357 (9268): 1571-1575.
Casaburi R. The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group. R. Casaburi, D.D. Jr Briggs., J.F. Donohue et al. Chest. 2000, 118: 1294-1302.
Vincken W. On behalf of the Dutch/Belgian Tiotropium Study Group. Improved health outcomes in patients with COPD during 1-yr's treatment with tiotropium. W. Vincken, J.A. van Noord, A.PM. Greefhorst et al. Eur Respir J, 2002, 19: 209-216.
Barr RG. Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis. R.G. Barr, J. Bourbeau, C.A Camargo, FS.F Ram. Thorax 2006, 61: 854-862.
Alsaeedi A. The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. A. Alsaeedi, D.D. Sin, F.A. McAlister. Am J Med 2002, 113(1): 59-65.
Gartlehner Effecacy and safety of inhaled corticosteroids in patients with COPD a systematic review and meta analysis of health outcomes. Gartlehner et al. AnnFam Med 2006, 4: 253-262.
Wongsurakiat P Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. P Wongsurakiat, K.N. Maranetra, C. Wasi et al. Chest 2004, 125 (6): 2011-2020.
Alfageme R. Clinical efficiacy of anti-pneumococcal vaccination in patients with COPD. R Alfageme, R Vazquez, N. Reyes, et al. Thorax, 2006, 61: 189-195.
Decramer M. Chronic obstructive pulmonary disease. Seminar. M Decramer et al. Lancet, 2012, 379: 1341-1351.
Woodhead M. Guidelines for the management of adult lower respiratory tract infections-full version. M. Woodhead et al. Clin Microbiol Infect, 2011, 17 (6): 1-59.
Козлов РС. Динамика резистентности Streptococcus pneumonia к антибиотикам в России за период 1999-2009 года (результаты многоцентрового проспективного исследования ПеГАС). Козлов РС. и соавт. Клин, микробиол. антимикроб. химиотер., 2010, 4: 329-341.